Maze Therapeutics, Inc.
MAZE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$34 | -$33 | -$30 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $3 | $3 | $3 |
| Change in WC | $2 | -$1 | -$1 | $1 |
| Other Non-Cash | -$1 | $1 | $1 | $3 |
| Operating Cash Flow | -$25 | -$30 | -$30 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$67 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$67 | -$0 | -$0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$16 |
| Stock Issued | -$128 | $1 | $128 | $70 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $272 | $0 | -$0 | $16 |
| Financing Cash Flow | $144 | $1 | $127 | $70 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $52 | -$30 | $98 | $47 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $266 | $295 | $198 | $151 |
| End Cash | $318 | $266 | $295 | $198 |
| Free Cash Flow | -$25 | -$30 | -$30 | -$23 |